Pipeline
Using its accelerated approach to drug discovery, Frontier is unlocking the proteome to develop a differentiated pipeline of small-molecule drugs against previously undruggable targets.


Platform
Frontier has identified thousands of opportunities across the proteome. This “Druggability Atlas” delivers novel covalent binding sites and actionable leads.
How Bold are You?
At Frontier we are boldly advancing our science to defeat disease – all on behalf of patients. Are you interested in becoming part of “the Frontier?”

